Teva Pharmaceuticals Moving U.S. Headquarters To New Jersey
Award of Merit Manufacturing: TEVA Biologics Manufacturing Facility | 2018-10-16 | Engineering News-Record
Pharma giant Teva promises to create over 800 jobs in N.J. Are they worth $40M? - nj.com
Battered by a Tough Generics Market, Teva Pharma Emphasizes Biologics | BioSpace
Teva Pharmaceutical Stock: Stuck In A Cycle Of Hope And Disappointment | Seeking Alpha
Settling a post-buyout hangover, Allergan gives Teva a $700M remedy | Fierce Pharma
Stark Wipes Out $235M Infringement Verdict Against Teva for Hypertension Drug | Delaware Business Court Insider
Patients Eagerly Awaited a Generic Drug. Then They Saw the Price. - The New York Times
Why Teva Pharmaceuticals Stock Has Two A-Products In The Bag (NYSE:TEVA) | Seeking Alpha
Teva Pharmaceutical begins first wave of layoffs in Kansas - Kansas City Business Journal
Teva stock drops on guidance, manufacturing problems - MarketWatch
Teva Announces Nationwide Opioids Settlement to Move Forward After Receiving Broad Support from States | Business Wire
Teva introduces QVAR RediHaler inhalation aerosol in US - Pharmaceutical Technology
Teva down as it reports lower sales and profit for 2018
Teva Pharmaceuticals Soars After Buffett's Berkshire Hathaway Discloses Stake
Teva concludes $703m women's health products deal with CVC Capital - Pharmaceutical Technology
A Drug Company Wagers the U.S. Won't Dare Charge It With Crimes - The New York Times
Teva 'Plagued By Problems,' Downgraded On Lost MS Drug Patents, DOJ Probe | Stock News & Stock Market Analysis - IBD
Teva Pharmaceuticals to lay off 14,000 employees worldwide, 1,750 in Israel - The Jerusalem Post
ADDING MULTIMEDIA Teva Announces U.S. Approval of AJOVYTM (fremanezumab-vfrm) Injection, the First and Only Anti-CGRP Treatment with Both Quarterly and Monthly Dosing for the Preventive Treatment of Migraine in Adults | Business
Teva Pharmaceutical | P3 Properties | NJ Office Market
Teva Faces Rocky Path to Recovery After Debt | Fortune
Teva Pharmaceutical Shares Plunge After Quarterly Loss and 2018 Outlook Warning - WSJ
Teva Pharmaceutical Stock: Prepare For Takeoff (NYSE:TEVA) | Seeking Alpha
Teva will appeal opioid liability ruling in New York trial -
